PTO Proposed Rule Could Force Drug Firms To File More Patent Applications
Executive Summary
Biotech and pharmaceutical companies may have to spend more time and money to patent their inventions under a new regulation proposed by the Patent and Trademark Office
You may also be interested in...
New Patent Rules May Hurt Biotech Industry; Limits Set On Certain Filings
The U.S. Patent and Trademark Office is implementing new rules on patent filings that will make it tougher for biotechnology companies to protect their inventions
Turning COVID-19 Vaccine EUA Into A BLA Will Require Six Months Of Additional Data
US FDA’s Peter Marks notes timeframe for sponsors to seek licensure at press call announcing emergency use authorization of J&J’s vaccine; Acting Commissioner Woodcock says effectiveness comparisons cannot be made between the three authorized vaccines since they have not been tested head-to-head.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: